| 000 | 01799cam a2200325 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 111019s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.32.M.Sc.2010.Sa.S | ||
| 100 | 0 | _aSabah Gaber Ali | |
| 245 | 1 | 0 |
_aSerum B cell - activating factor levels in patients with systemic sclerosis : _bCorrelation with disease severity / _cSabah Gaber Ali ; Supervised Manal Sedky Abdo , Hala Mohamed Raslan , Reem Hamdy A. Mohammed |
| 246 | 1 | 5 |
_aمستوى العامل المنشط لخلايا ب فى مصل الدم لمرضى تصلب الانسجة الشامل : _bعلاقتة بشدة المرض |
| 260 |
_aCairo : _bSabah Gaber Ali , _c2010 |
||
| 300 |
_a129 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Rheumatology and Rehabilitation | ||
| 520 | _aThe aim of the present study was to assess serum BAFF levels in patients with systemic sclerosis and to correlate it with disease features , treatment received and disease severity . We can conclude that serum BAFF levels were significantly elevated in patients with SSc irrespective of disease subtype , disease duration or age of patients . This elevation in serum BAFF was significantly related to GIT involvement and MTX | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aModified rodnon skin thickness score and disease severity scale | |
| 653 | 4 | _aSerum BAFF | |
| 653 | 4 | _aSystemic sclerosis | |
| 700 | 0 |
_aHala Mohamed Raslan , _eSupervisor |
|
| 700 | 0 |
_aManal Sedky Abdo , _eSupervisor |
|
| 700 | 0 |
_aReem Hamdy A. Mohammed , _eSupervisor |
|
| 905 |
_aFatma _eCataloger |
||
| 905 |
_aNazla _eRevisor |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c35874 _d35874 |
||